• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对躯体化障碍患者的精神科干预措施的有效性:降低成本并改善治疗效果。

Effectiveness of psychiatric intervention with somatization disorder patients: improved outcomes at reduced costs.

作者信息

Rost K, Kashner T M, Smith R G

机构信息

NIMH Center for Rural Mental Healthcare Research Little Rock, Arkansas.

出版信息

Gen Hosp Psychiatry. 1994 Nov;16(6):381-7. doi: 10.1016/0163-8343(94)90113-9.

DOI:10.1016/0163-8343(94)90113-9
PMID:7843574
Abstract

In order to determine the health effects of an intervention that reduces the cost of care for somatization disorder (SD) patients, 59 primary care physicians were randomized to receive a psychiatric consultation letter providing treatment recommendations for 73 patients either at baseline or the end of the year-long study. Seventy of these patients (96%) were followed every 4 months for 1 year by a research assistant blind to randomization. A year following the intervention, patients of experimental physicians reported greater physical capacity than patients of control physicians (mean difference = 17.9, 95% CI 1.0-34.9) with a $466 reduction (95% CI $132-$699) in health care charges. In addition to a net 21% reduction in health care charges for the typical SD patient, the consultation letter improved physical functioning in a group of highly impaired subjects.

摘要

为了确定降低躯体化障碍(SD)患者护理成本的干预措施对健康的影响,59名初级保健医生被随机分组,在基线期或为期一年的研究结束时收到一份精神科会诊信,其中为73名患者提供了治疗建议。这些患者中有70名(96%)由对随机分组不知情的研究助理每4个月随访1年。干预一年后,实验组医生的患者报告的身体能力高于对照组医生的患者(平均差异=17.9,95%置信区间1.0-34.9),医疗费用降低了466美元(95%置信区间132美元-699美元)。除了典型SD患者的医疗费用净降低21%外,会诊信还改善了一组严重受损受试者的身体功能。

相似文献

1
Effectiveness of psychiatric intervention with somatization disorder patients: improved outcomes at reduced costs.针对躯体化障碍患者的精神科干预措施的有效性:降低成本并改善治疗效果。
Gen Hosp Psychiatry. 1994 Nov;16(6):381-7. doi: 10.1016/0163-8343(94)90113-9.
2
A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patients.一项关于标准化精神科会诊对躯体化患者健康结局及费用影响的试验。
Arch Gen Psychiatry. 1995 Mar;52(3):238-43. doi: 10.1001/archpsyc.1995.03950150070012.
3
Psychiatric consultation in somatization disorder. A randomized controlled study.躯体化障碍的精神科会诊:一项随机对照研究。
N Engl J Med. 1986 May 29;314(22):1407-13. doi: 10.1056/NEJM198605293142203.
4
An analysis of panel data. The impact of a psychiatric consultation letter on the expenditures and outcomes of care for patients with somatization disorder.面板数据分析。精神科会诊信对躯体化障碍患者护理费用及治疗结果的影响。
Med Care. 1992 Sep;30(9):811-21.
5
Cost-effectiveness Analysis of a Stepped, Collaborative and Coordinated Health Care Network for Patients with Somatoform Disorders (Sofu-Net).躯体形式障碍患者阶梯式、协作与协调医疗保健网络(Sofu-Net)的成本效益分析
J Ment Health Policy Econ. 2018 Jun 1;21(2):59-69.
6
Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity.躯体化增加了医疗利用率和费用,且与精神疾病和躯体疾病共病无关。
Arch Gen Psychiatry. 2005 Aug;62(8):903-10. doi: 10.1001/archpsyc.62.8.903.
7
Enhancing the health of somatization disorder patients. Effectiveness of short-term group therapy.
Psychosomatics. 1995 Sep-Oct;36(5):462-70. doi: 10.1016/S0033-3182(95)71627-9.
8
Consultation letters for medically unexplained physical symptoms in primary care.基层医疗中关于医学上无法解释的身体症状的会诊信。
Cochrane Database Syst Rev. 2010 Dec 8(12):CD006524. doi: 10.1002/14651858.CD006524.pub2.
9
Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial.躯体化障碍的认知行为疗法:一项随机对照试验。
Arch Intern Med. 2006 Jul 24;166(14):1512-8. doi: 10.1001/archinte.166.14.1512.
10
Resource utilization of patients with hypochondriacal health anxiety and somatization.疑病性健康焦虑和躯体化患者的资源利用情况。
Med Care. 2001 Jul;39(7):705-15. doi: 10.1097/00005650-200107000-00007.

引用本文的文献

1
Medically Unexplained Physical Symptoms: What They Are and Why Counseling Psychologists Should Care about Them.医学上无法解释的身体症状:它们是什么以及咨询心理学家为何应关注它们。
Couns Psychol. 2019 Jul 1;47(5):741-769. doi: 10.1177/0011000019888874.
2
Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults.成人躯体形式障碍和医学无法解释的身体症状(MUPS)的非药物干预措施。
Cochrane Database Syst Rev. 2014 Nov 1;2014(11):CD011142. doi: 10.1002/14651858.CD011142.pub2.
3
A randomized trial of treatments for high-utilizing somatizing patients.
高利用躯体化患者治疗的随机试验。
J Gen Intern Med. 2013 Nov;28(11):1396-404. doi: 10.1007/s11606-013-2392-6. Epub 2013 Mar 14.
4
Effectiveness of a cognitive behavioral intervention in patients with medically unexplained symptoms: cluster randomized trial.一项认知行为干预对有医学无法解释症状患者的有效性:整群随机试验。
BMC Fam Pract. 2012 May 2;13:35. doi: 10.1186/1471-2296-13-35.
5
The treatment of patients with medically unexplained symptoms in primary care: a review of the literature.基层医疗中对具有医学上无法解释症状患者的治疗:文献综述
Ment Health Fam Med. 2010 Dec;7(4):209-21.
6
Consultation psychiatry in the medical home and accountable care organizations: achieving the triple aim.医疗之家和责任医疗组织中的会诊精神病学:实现三重目标。
Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):305-10. doi: 10.1016/j.genhosppsych.2011.05.011. Epub 2011 Jun 15.
7
Psychophysiologic treatment for patients with medically unexplained symptoms: a randomized controlled trial.精神心理生理治疗对患有医学无法解释症状的患者:一项随机对照试验。
Psychosomatics. 2011 May-Jun;52(3):218-29. doi: 10.1016/j.psym.2011.01.015.
8
On-site mental health workers delivering psychological therapy and psychosocial interventions to patients in primary care: effects on the professional practice of primary care providers.为初级保健患者提供心理治疗和社会心理干预的现场心理健康工作者:对初级保健提供者专业实践的影响
Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD000532. doi: 10.1002/14651858.CD000532.pub2.
9
Advances in understanding illness anxiety.疾病焦虑症认识上的进展
Curr Psychiatry Rep. 2008 Aug;10(4):311-7. doi: 10.1007/s11920-008-0050-1.
10
[Somatoform disorders. Clinical evidence, etiology, pathogenesis, and therapy].
Nervenarzt. 2008 Jan;79(1):99-115; quiz 116-7. doi: 10.1007/s00115-007-2388-8.